High quality, highly accessible healthcare For all © 2 0 2 5 A l l R i g h t s R e s e r ve d – D oc Go Disclaimer This presentation is being delivered solely for informational purposes. No representation or warranty, express or implied, is made by DocGo, its affiliates, or any of their respective directors, officers, shareholders, members, partners or representatives as to the accuracy or completeness of any information in this presentation. Except where otherwise indicated, this presentation speaks as of ...

DocGo (DCGO) Q1 2025 Earnings Call May 08, 2025 05:00 PM ET Company Participants Michael Cole - VP - Investor RelationsLee Bienstock - Chief Executive OfficerNorman Rosenberg - Treasurer & CFOGabrielle Ingoglia - Equity Research AssociateJenny Shen - Equity Research Associate Conference Call Participants Ryan Macdonald - Senior AnalystKieran Ryan - Analyst Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo First Quarter Earnings Conference Call. At this time, all lines are in listen onl ...

DocGo (DCGO) Q1 2025 Earnings Call May 08, 2025 05:00 PM ET Speaker0 Good afternoon, ladies and gentlemen, and welcome to the DocGo First Quarter Earnings Conference Call. At this time, all lines are in listen only mode. Following the presentation, we will conduct a question and answer session. This call is being recorded on a Thursday, 05/08/2025. I would now like to turn the conference over to Mike Cole, VP of Investor Relations. Please go ahead. Speaker1 Thank you, operator. Before turning the call over ...

Core Insights - Kahn Swick & Foti, LLC (KSF) is investigating DocGo Inc. following allegations of misrepresentation regarding its contracts and executive conduct [1][2] - DocGo's contract with U.S. Customs and Border Protection (CBP) was reported to be worth under $2 billion, contrary to the company's claim of $4 billion [2] - The CEO of DocGo resigned due to fabricated elements of his educational background [2] - A securities class action lawsuit has been filed against DocGo and its executives for failing to disclose material information and violating federal securities laws [3] - The court has denied DocGo's motion to dismiss the lawsuit, allowing it to proceed [3] - KSF's investigation is focused on potential breaches of fiduciary duties by DocGo's officers and directors [3] Company Overview - DocGo is a healthcare company that provides medical transportation and mobile health services in the U.S. and the U.K. [2] - The company is currently facing legal challenges due to allegations of corporate misconduct [3] Legal Context - KSF is a prominent securities litigation law firm, ranked among the top 10 firms nationally based on total settlement value [4] - The firm is seeking information from individuals who may assist in the investigation or have been long-term holders of DocGo shares [4]

DocGo, Inc (NASDAQ:DCGO) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants Mike Cole - VP of Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Richard Close - Canaccord Genuity David Larsen - BTIG Aidan Conniff - Stifel Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo Fourth Quarter and Full Year 2024 Earnings Call. At this time, all lines ar ...